Filter Results:
(114)
Show Results For
- All HBS Web
(461)
- Faculty Publications (114)
Show Results For
- All HBS Web
(461)
- Faculty Publications (114)
←
Page 6 of 114
Results
- August 2000
- Article
Discussion of 'Venture Capital Investment' by Gavin Reid
By: Josh Lerner
Lerner, Josh. "Discussion of 'Venture Capital Investment' by Gavin Reid." Small Business Economics 15 (August 2000): 77–78.
- June 1999 (Revised March 2001)
- Case
New Business Investment Company: October 1997
By: Josh Lerner, Lee Branstetter and Takeshi Nakabayashi
A quasi-government organization seeks to stimulate entrepreneurship in Japan by making venture capital investments. The organization of the fund, identification of transactions, and oversight of portfolio firms pose considerable challenges. View Details
Keywords: Venture Capital; Entrepreneurship; Government and Politics; Problems and Challenges; Financial Services Industry; Japan
Lerner, Josh, Lee Branstetter, and Takeshi Nakabayashi. "New Business Investment Company: October 1997." Harvard Business School Case 299-025, June 1999. (Revised March 2001.)
- March 1999
- Article
Discussion of "Engineering Bureaucracy: The Genesis of Formal Policies, Positions, and Structures in High-Technology Firms" by James N. Baron, M. Diane Burton, and Michael T. Hannan
By: Josh Lerner
Lerner, Josh. Discussion of "Engineering Bureaucracy: The Genesis of Formal Policies, Positions, and Structures in High-Technology Firms" by James N. Baron, M. Diane Burton, and Michael T. Hannan. Special Issue on Bureaucracy: Issues and Apparatus Journal of Law, Economics & Organization 15, no. 1 (March 1999): 42–46.
- August 1998
- Article
Discussion of 'Venture Capital Financing, Moral Hazard, and Learning' by Dirk Bergemann and Ulrich Hege
By: Josh Lerner
Lerner, Josh. "Discussion of 'Venture Capital Financing, Moral Hazard, and Learning' by Dirk Bergemann and Ulrich Hege." Special Issue on The Economics of Small Business Finance Journal of Banking & Finance 22, nos. 6-8 (August 1998): 736–740.
- January 1996
- Case
Outrage in Cyberspace: CompuServe and the GIF Patent
By: Josh Lerner and Benjamin Conway
CompuServe, an online services vendor, informs its software developers that they must enter into a licensing agreement to use the popular GIF compression. CompuServe claims that it is forced to do so because Unisys is enforcing its patent rights in this area. Others... View Details
Keywords: Patents; Technological Innovation; Internet and the Web; Information Technology; Competitive Strategy; Internet and the Web; Web Services Industry
Lerner, Josh, and Benjamin Conway. "Outrage in Cyberspace: CompuServe and the GIF Patent." Harvard Business School Case 296-057, January 1996.
- September 1995 (Revised May 1998)
- Case
RogersCasey Alternative Investments: Innovative Response to the Distribution Challenge
By: Josh Lerner
RogersCasey Alternative Investments faces the challenge of managing distributions of stock by the private equity investors in which their clients have invested. These distributed shares appear to behave in complex ways, apparently at odds with market efficiency. A... View Details
Keywords: Private Equity; Stocks; Financial Strategy; Investment; Innovation Strategy; Management; Distribution; Performance; Behavior
Lerner, Josh. "RogersCasey Alternative Investments: Innovative Response to the Distribution Challenge." Harvard Business School Case 296-024, September 1995. (Revised May 1998.)
- January 1995 (Revised November 1995)
- Case
Candela Laser vs. Cynosure, Inc.
By: Josh Lerner and Benjamin Conway
Summarizes the lawsuit by Candela Laser against its former CEO and founder, who has begun a competing firm. The extent of patent and trade secret protection are crucial issues. View Details
Lerner, Josh, and Benjamin Conway. "Candela Laser vs. Cynosure, Inc." Harvard Business School Case 295-097, January 1995. (Revised November 1995.)
- January 1995
- Background Note
A Note on Distribution of Venture Investments
By: Josh Lerner
Venture capitalists typically exit investments by distributing shares to investors. These transfers pose challenges for these investors. Predictions and evidence about the behavior of stock prices of firms around the time of these distributions are presented. View Details
Lerner, Josh. "A Note on Distribution of Venture Investments." Harvard Business School Background Note 295-095, January 1995.
- January 1994 (Revised April 2011)
- Background Note
Note on Private Equity Partnership Agreements
By: Josh Lerner
Venture capital by necessity is a long-run investment. Consequently, since the mid-1960s virtually all venture financing has been raised through private partnerships with a ten-year or longer life span. To govern these investments, complex contracts have sprung up... View Details
Keywords: Venture Capital; Financing and Loans; Investment; Governance; Contracts; Partners and Partnerships
Lerner, Josh. "Note on Private Equity Partnership Agreements." Harvard Business School Background Note 294-084, January 1994. (Revised April 2011.)
- December 1992 (Revised September 1996)
- Case
ImmuLogic Pharmaceutical Corporation (Abridged)
By: Josh Lerner
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The rationales for and problems of high-technology start-ups are explored. The challenges posed by "windows" for public offerings are... View Details
Keywords: Decisions; Initial Public Offering; Entrepreneurship; Going Public; Business Startups; Biotechnology Industry; Pharmaceutical Industry; United States
Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (Abridged)." Harvard Business School Case 293-087, December 1992. (Revised September 1996.)
- October 1992 (Revised November 1997)
- Case
ImmuLogic Pharmaceutical Corporation (A): March 1991
By: Josh Lerner
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems... View Details
Keywords: Decisions; Entrepreneurship; Venture Capital; Banks and Banking; Initial Public Offering; Going Public; Perspective; Valuation; Biotechnology Industry; Pharmaceutical Industry
Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (A): March 1991." Harvard Business School Case 293-066, October 1992. (Revised November 1997.)
- Research Summary
Overview
In examining the competitive dynamics of R&D strategy, Josh has become particularly interested in how the introduction of new knowledge generated by rivals impacts the direction of R&D efforts. Understanding how new information alters project portfolio decisions is... View Details
- Forthcoming
- Article
The (Heterogenous) Economic Effects of Private Equity Buyouts
By: Steven J. Davis, John Haltiwanger, Kyle Handley, Ben Lipsius, Josh Lerner and Javier Miranda
The effects of private equity buyouts on employment, productivity, and job reallocation vary
tremendously with macroeconomic and credit conditions, across private equity groups, and by
type of buyout. We reach this conclusion by examining the most extensive... View Details
Keywords: Private Equity Buyouts; Impact; Private Equity; Economics; Employment; Performance Productivity; Wages
Davis, Steven J., John Haltiwanger, Kyle Handley, Ben Lipsius, Josh Lerner, and Javier Miranda. "The (Heterogenous) Economic Effects of Private Equity Buyouts." Management Science (forthcoming). (Earlier version distributed as National Bureau of Economic Research Working Paper No. 26371 and Harvard Business School Working Paper No. 20-030. Related discussion published as “Private Equity Buyout and Their Effects,” VoxEU, 2019.)
- Teaching Interest
Venture Capital and Private Equity (MBA)
By: Josh Lerner
The growth of private equity internationally has been dramatic, to the point that the asset class has been both lauded as the savior and vilified as the cause of our current economic malaise. Over the past two decades, private equity- ranging from venture capital to... View Details
- ←
- 6